TAP
64
3
KIM
48
-6
NOC
35
-2
PSX
42
5
HBAN
65
5
DVN
28
3
IPG
53
3
PH
73
3
PLD
56
13
PEP
41
-3
PSA
46
-2
FTI
58
5
PPL
54
-5
RCL
76
3
WM
79
2
DTE
75
3
CMS
61
-6
JCI
57
2
PAYX
44
-6
MUR
39
3
TAP
64
3
KIM
48
-6
NOC
35
-2
PSX
42
5
HBAN
65
5
DVN
28
3
IPG
53
3
PH
73
3
PLD
56
13
PEP
41
-3
PSA
46
-2
FTI
58
5
PPL
54
-5
RCL
76
3
WM
79
2
DTE
75
3
CMS
61
-6
JCI
57
2
PAYX
44
-6
MUR
39
3
Financhill
Back

The Hain Celestial Group Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
17

HAIN
The Hain Celestial Group

Last Price:
$3.99
Seasonality Move:
3.02%
Sell
41

SRPT
Sarepta Therapeutics

Last Price:
$105.29
Seasonality Move:
1.75%
Sell
17
The Hain Celestial Group (HAIN) is a Sell

Is The Hain Celestial Group a Buy, Sell or Hold?

  • The current The Hain Celestial Group [HAIN] share price is $4.05. The Score for HAIN is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
  • HAIN is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
41
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $107.95. The Score for SRPT is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

HAIN Stock Price Chart

What is The Hain Celestial Group's stock price today?

  • The The Hain Celestial Group share price today is $4.05
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HAIN is experiencing selling pressure, which indicates risk of future bearish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $107.95
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

HAIN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.42 Sell
Relative Strength Index (14 RSI): 30.44 Sell
Chaikin Money Flow: -1716010 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (4.48 - 5.12) Sell
Bollinger Bands (100): (5.5 - 8.66) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.94 Sell
Relative Strength Index (14 RSI): 33.84 Sell
Chaikin Money Flow: -502758 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (111.52 - 119.16) Sell
Bollinger Bands (100): (114.38 - 127.78) Sell

HAIN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 4.47 Sell
20-day SMA: 4.8 Sell
50-day SMA: 5.9 Sell
200-day SMA: 7.18 Sell
8-day EMA: 4.45 Sell
20-day EMA: 4.8 Sell
50-day EMA: 5.66 Sell
200-day EMA: 7.35 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 111.57 Sell
20-day SMA: 114.25 Sell
50-day SMA: 119.8 Sell
200-day SMA: 128.55 Sell
8-day EMA: 110.88 Sell
20-day EMA: 113.91 Sell
50-day EMA: 117.81 Sell
200-day EMA: 123.39 Sell

The Hain Celestial Group Earnings Growth & HAIN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, an increase next quarter of $0.05 per share, an increase this year of $0.08 per share, and an increase next year of $0.13 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.70 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.63 per share, and an increase next year of $4.84 per share.

The Hain Celestial Group Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):